Udenyca Copay Assistance

ቤት / Udenyca Copay Assistance

አሁን የገንዘብ እፎይታ ያግኙ

Apply for Udenyca Copay Assistance

የነጻ አገልግሎት ከከፍተኛ የቅጅ ክፍያ እርዳታ ፕሮግራሞች ጋር ያዛምዳል
በማመልከቻው ሂደት ውስጥ ስፔሻሊስቶች ይረዱዎታል
በእርስዎ የገንዘብ ድጋፍ ሁኔታ ላይ ራስ-ሰር ዝማኔዎችን ያግኙ
እስካሁን ከ$55 ሚሊዮን በላይ ለታካሚዎቻችን ዋስትና ተሰጥቷል።

ከአንድ ስፔሻሊስት ጋር ይነጋገሩ

እርዳታ እንዴት እንደሚሰራ

የታካሚያችንን ልዩ መድሃኒት ቤት ልምድ በማይዛመድ የሙሉ አገልግሎት ምቾት ማቀላጠፍ

1. የሽፋን/የጥቅማ ጥቅሞች ማረጋገጫዎን ያረጋግጡ

የእኛ የባለሙያዎች የሂሳብ አከፋፋዮች ቡድን ከኪስ ወጪዎች የሚቀንሱትን ምርጥ የሽፋን መንገዶችን ያገኛል።
2. ማዘዣን ወደ AmeriPharma® ያስተላልፉ

ከቀድሞው ፋርማሲዎ ወይም ከሐኪምዎ ጋር በመስራት ማዘዙን እናሰራለን፣ ይህም ሽግግሩን ፈጣን እና ቀላል ያደርገዋል።
3. የቅድሚያ ፍቃድ

የእኛ የስፔሻሊስቶች ቡድን ከ24 እስከ 72 ሰአታት ውስጥ ከኢንሹራንስ ኩባንያዎችዎ ፈቃድ ያገኛል።
4. የቅጅ ክፍያ እርዳታ እና የገንዘብ እርዳታ

የገንዘብ ዕርዳታን እናስከብራለን እና የጋራ ክፍያን፣ ከኪስ ውጪ ወጪዎችን እና ከፍተኛ ተቀናሾችን እንቀንሳለን። እስካሁን፣ AmeriPharma® ስፔሻላይቲ ኬር $55 ሚሊዮን ለታካሚዎቻችን የገንዘብ ድጋፍ አግኝቷል።
5. አስፈላጊ ከሆነ የነርሲንግ እንክብካቤ ማስተባበር

AmeriPharma® በቤት ውስጥ ለሚደረጉ መርፌዎች ከኛ ልዩ ነርሶች ውስጥ አንዱን ሲያቀናጅ እና ሲያስተባብር የእርስዎን የጊዜ ሰሌዳ እና የቤት አካባቢ ያስቀድማል።
6. የመላኪያ ማስተባበር

መድሃኒቶች ሁልጊዜ የሚቀርቡት ለማጓጓዣ ልዩ መስፈርቶች በጥብቅ በማክበር ነው. በሚቀጥለው ቀን እና በሌሊት የቀዝቃዛ ሰንሰለት ማቅረቢያዎች በጊዜ ሰሌዳዎ ዙሪያ የተቀናጁ ናቸው።

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/pharmacist.jpg

What Is Udenyca?

Udenyca is a biosimilar (similar in molecular structure and function) of pegfilgrastim.

Pegfilgrastim is a medication that supports the growing process of stem cells in the bone marrow and aids patients who undergo chemotherapy in replenishing their white blood cell count. Pegfilgrastim contains a PEG (polyethylene glycol) component compared to filgrastim. This allows this medication to stay in the body longer, which leads to less dosing frequency.

Udenyca is a man-made product that mimics a substance in our bodies. It helps stimulate the growth of neutrophils in the human body, which plays a big role in protecting the patient against infections.

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image_1.jpg

What is Udenyca Used For?

Udenyca is a biosimilar injection. Biosimilars are FDA-approved medications that are made to be as safe and effective as the original biologics. There are no clinically meaningful differences between a biosimilar and the original medication.

Udenyca is an FDA-approved medication that is administered after chemotherapy to help reduce the incidence of infections. Patients with non-myeloid malignancies who receive myelosuppressive anti-cancer medications are usually susceptible to an increased risk for febrile (showing fever) neutropenia (lower than normal neutrophil count). This decreases the patient’s ability to fight off infection and puts a patient at greater risk of getting one. Neutrophils are a type of white blood cell that helps in fighting an infection and Udenyca can play a role in repleting one’s neutrophil count.

የቅጅ ክፍያ እና የገንዘብ ድጋፍ

AmeriPharma™ ልዩ ፋርማሲ ለታካሚዎች እና ለቤተሰቦቻቸው የገንዘብ ሸክሞችን ያቃልላል

የላቀ ሶፍትዌር እርስዎን ከከፍተኛ-ዶላር ፋውንዴሽን ፕሮግራሞች ጋር ለማዛመድ የገንዘብ ምንጮችን ያገኛል
የእኛ የጋራ ክፍያ እርዳታ ስፔሻሊስቶች በማመልከቻው ሂደት ላይ ያግዛሉ።
በገንዘቡ ሁኔታ ላይ አውቶማቲክ ማሻሻያ ለእርስዎ እና ለሐኪምዎ ይላካል

https://ameripharmaspecialty.com/wp-content/uploads/2024/05/doctor-patient.jpg

Udenyca Administration Information

Udenyca comes in a 6 mg/0.6 ml prefilled syringe. Udenyca is administered subcutaneously, into the fatty layer between the muscle and the skin. It is administered once per chemotherapy cycle after the completion of the chemotherapy regimen. For pediatric patients weighing less than 10 kg, administer 0.1 mg/kg of Udenyca. Administration of less than 0.6 ml is not recommended as it may potentially lead to dosing errors.

Do not administer Udenyca between 14 days before or 24 hours after the administration of cytotoxic chemotherapy.

The carton should be removed from the fridge and left to sit at room temperature for a minimum of 30 minutes prior to injection. Discard any prefilled syringe if left at room temperature for 48 hours or more.

Do not administer Udenyca if there is any discoloration or particulate matter detected in the prefilled syringe.

Avoid use of heat sources (such as tanning beds, heating pads, electric blankets, saunas, and hot tubs). Avoid long, hot baths or sunbathing. Excessive heat may cause your body temperature to rise, potentially causing accelerated metabolism of the drug.

Do not travel, drive, or do other tasks or actions that require alertness during hours 26 through 29 after the injection.

Udenyca Side Effects

ከባድ የጎንዮሽ ጉዳቶች የሚከተሉትን ያካትታሉ:

Spleen rupture – enlargement of the spleen may lead to spleen rupture which can cause pain in the left upper stomach area
Acute respiratory distress syndrome (ARDs) – fluid leakage in the lungs that can lead to serious lung problems such as:
- Shortness of breath with or without fever
- Trouble breathing
- Fast rate of breathing
Myelodysplastic syndrome and acute myeloid leukemia – Udenyca may increase the risk of blood cancer in patients who have breast or lung cancer
Leukocytosis (increased white blood cell count)
Glomerulonephritis (kidney injury)
Swelling in the face or ankle
Blood in the urine
Severe allergic reactions (anaphylaxis) such as:
- Full body rash
- የትንፋሽ እጥረት
- የልብ ምት መጨመር
- ላብ
- መፍዘዝ
Sickle cell crisis – Using Udenyca in patients with sickle cell anemia may lead to death